Limited Coverage Drugs - Special Authority Criteria

Generic Name / Strength / Form
mercaptopurine

Criteria Approval Period
1. Diagnosis of ulcerative colitis.

OR

2. Diagnosis of autoimmune hepatitis.

OR

3. Diagnosis of inflammatory bowel disease.

OR

4. Diagnosis of Crohn's disease.

 Indefinite

Practitioner Exemptions

  • No practitioner exemptions

Special Notes

  • For any cancer related condition, please contact the British Columbia Cancer Agency at (604) 877-6098 ext. 4610.

Online Forms (PDF)
Click on the link to complete a special authority request form.